A 2-Month Safety Follow-Up Trial

NCT ID: NCT00741429


Title
A 2-Month Safety Follow-up Trial of Subjects From MannKind Protocols MKC-TI-009, MKC-TI-102, MKC-TI-103 and MKC-TI-030
Purpose
The main purpose of the trial is to evaluate pulmonary function in subjects who had completed any one of the 4 MKC parent trials (MKC-TI-009, MKC-TI-102, MKC-TI-103, or MKC-TI-030) for an additional 2-month safety follow-up.
Details
This was a 2-month safety follow-up study of subjects from MannKind protocols MKC-TI-009, MKC-TI-102, MKC-TI-103 and MKC-TI-030. No study medications were administered during this trial. The adverse event data included are for the combined Safety population irrespective of previous treatments in the parent trials.
Conditions
Type 1 Diabetes, Type 2 Diabetes
Keywords
Source
Mannkind Corporation
Sponsors
Mannkind Corporation
Status
Completed
Acronym
Last Updated
30 Nov 2014
URL
Official Link
Locations
Brazil, Canada, Russian Federation, United States